Inventor
Ken Ishii
Inventor
Osaka, JP
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
Y02ATechnologies for adaptation to climate change19%
C12NMicroorganisms or enzymes9%
C07HSugars8%
A01KAnimal husbandry3%
C07KPeptides3%
Y10TTechnical subjects covered by former us classification3%
C08BPolysaccharides2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
11,058,758TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same202111,015,202Complex containing oligonucleotide having immunopotentiating activity and use thereof202110,202,606Complex containing oligonucleotide having immunopotentiating activity and use thereof201910,172,927Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction20199,732,107'Method for producing beta-hematin crystal comprising step of heating'20179,400,279'Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction'20169,056,094'Adjuvant'20159,028,843'Malaria vaccine'20158,894,996'Immunoadjuvant composition and use thereof'20148,846,867'Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies'20148,808,712'Malaria vaccine'20148,741,869'Oligodeoxynucleotide and its use to induce an immune response'20148,389,495'Olioodeoxynucleotide and its use to induce an immune response'20138,232,259'Multiple CpG oligodeoxynucleotide and their use to induce an immune response'20128,227,446'Oligodeoxynucleotide and its use to induce an immune response'20128,030,285'Oligodeoxynucleotide and its use to induce an immune response'20117,960,356'Oligodeoxynucleotide and its use to induce an immune response'20117,919,477'Multiple CpG oligodeoxynucleotides and their use to induce an immune response'20117,666,674'Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo'20107,521,063'Multiple CPG oligodeoxynucleotides and their use to induce an immune response'20096,977,245'Oligodeoxynucleotide and its use to induce an immune response'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2014Patents assigned to US HEALTH (10)· patent assignee history
2005–2019Based in Osaka, JP· patent location history
2009–2012Based in Columbia, MD, US· patent location history
2011–2013Based in Rockville, MD, US· patent location history
2012–2016Patents assigned to ISHII KEN (8)· patent assignee history
2012–2013Patents assigned to KLINMAN DENNIS (3)· patent assignee history
2014–2019Patents assigned to UNIV OSAKA (7)· patent assignee history
2014–2016Patents assigned to AKIRA SHIZUO (3)· patent assignee history
2014Based in Tokyo, JP· patent location history
2019–2021Based in Ibaraki, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 10 | 2005–2014 |
| ISHII KENself | 8 | 2012–2016 |
| UNIV OSAKA | 7 | 2014–2019 |
| AKIRA SHIZUO | 3 | 2014–2016 |
| KLINMAN DENNIS | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Osaka, JP | 10 | 2005–2019 |
| Ibaraki, JP | 3 | 2019–2021 |
| Rockville, Maryland, US | 3 | 2011–2013 |
| Columbia, Maryland, US | 3 | 2009–2012 |
| Tokyo, JP | 1 | 2014 |